Cat.#: ACPP-1356
| Despition | GIRK2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1008 | Recombinant Human Siglec 7 Protein (6×His Tag) (AC1008) | 50 µg | inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
| ACPP-1713 | Human SNCB Protein (AC1713) | 10 µg | inquiry |
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1430 | Human Pleiotrophin Protein, His (AC1430) | 5 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1128 | Recombinant Human Vimentin Protein (AC1128) | 25 µl | inquiry |
| ACPP-1175 | Recombinant Mouse Syndecan-1 Protein (Fc Tag) (AC1175) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.